Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy

Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy

Three years after measles, mumps, and rubella revaccination in 38 human immunodeficiency virus-infected children who had achieved immune recovery after antiretroviral therapy, the prevalence of protective antibody levels was 85% for measles, 61% for mumps, and 79% for rubella, compared with 88%, 84%...

Full description

Saved in:
Bibliographic Details
Main Authors: Linda Aurpibul, Thanyawee Puthanakit, Thira Sirisanthana, Virat Sirisanthana
Format: Journal
Published: 2018
Subjects:
Medicine
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77951814475&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/51070
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-51070
record_format dspace
spelling th-cmuir.6653943832-510702018-09-04T04:51:09Z Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy Linda Aurpibul Thanyawee Puthanakit Thira Sirisanthana Virat Sirisanthana Medicine Three years after measles, mumps, and rubella revaccination in 38 human immunodeficiency virus-infected children who had achieved immune recovery after antiretroviral therapy, the prevalence of protective antibody levels was 85% for measles, 61% for mumps, and 79% for rubella, compared with 88%, 84%, and 100%, respectively, 1 month after revaccination. © 2010 by the Infectious Diseases Society of America. All rights reserved. 2018-09-04T04:51:09Z 2018-09-04T04:51:09Z 2010-05-15 Journal 10584838 2-s2.0-77951814475 10.1086/652150 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77951814475&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/51070
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
topic Medicine
spellingShingle Medicine
Linda Aurpibul
Thanyawee Puthanakit
Thira Sirisanthana
Virat Sirisanthana
Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
description Three years after measles, mumps, and rubella revaccination in 38 human immunodeficiency virus-infected children who had achieved immune recovery after antiretroviral therapy, the prevalence of protective antibody levels was 85% for measles, 61% for mumps, and 79% for rubella, compared with 88%, 84%, and 100%, respectively, 1 month after revaccination. © 2010 by the Infectious Diseases Society of America. All rights reserved.
format Journal
author Linda Aurpibul
Thanyawee Puthanakit
Thira Sirisanthana
Virat Sirisanthana
author_facet Linda Aurpibul
Thanyawee Puthanakit
Thira Sirisanthana
Virat Sirisanthana
author_sort Linda Aurpibul
title Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
title_short Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
title_full Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
title_fullStr Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
title_full_unstemmed Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
title_sort persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in hiv-infected children receiving antiretroviral therapy
publishDate 2018
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77951814475&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/51070
_version_ 1681423703488856064

Similar Items